Home > branaplam

molecules of the month

<< Back to March

oral, CNS-penetrant splicing modulator w/ HTT activity - Novartis, Cambridge, MA

branaplam

Recent Publication

oral, CNS-penetrant splicing modulator w/ HTT activity

in Ph. II for Huntington's (prev. SMA)

further characterization of SMA candidate

Nat. Commun.

Novartis, Cambridge, MA

Context. Branaplam (Novartis Institutes for Biomedical Research) is an oral brain-penetrant splicing modulator, originally developed as a small molecule splicing modulator for spinal muscular atrophy (SMA). It turns out…

this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.

Join Now

white

branaplam

this content is exclusive to Premium members

this content is exclusive to
Premium members